beta-D-GlcpNAc-(1->2)-beta-D-Galp-(1->3)-alpha-D-GalpNAc

Term ID

CHEBI:71324

Synonyms

2-acetamido-2-deoxy-beta-D-glucopyranosyl-(1->2)-beta-D-galactopyranosyl-(1->3)-2-acetamido-2-deoxy-alpha-D-galactopyranose
beta-D-GlcNAc-(1->2)-beta-D-Gal-(1->3)-alpha-D-GalNAc
GlcNAcb1-2Galb1-3GalNAca
GlcNAcbeta1-2Galbeta1-3GalNAcalpha
N-acetyl-beta-D-glucosaminyl-(1->2)-beta-D-galactosyl-(1->3)-N-acetyl-alpha-D-glucosamine
O-2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl-(1->2)-O-beta-D-galactopyranosyl-(1->3)-2-(acetylamino)-2-deoxy-alpha-D-galactopyranose

Definition

An amino trisaccharide consisting of N-acetyl-β-D-glucosamine, β-D-galactose and N-acetyl-D-galactosamine residues linked sequentially (1→2) and (1→3).

References

glygen:G76607YV
glytoucan:G76607YV
pubmed:19443021
pubmed:25568069
pubmed:31537530

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from beta-D-GlcpNAc-(1->2)-beta-D-Galp-(1->3)-alpha-D-GalpNAc

Phenotype where environments contain beta-D-GlcpNAc-(1->2)-beta-D-Galp-(1->3)-alpha-D-GalpNAc

Phenotype modified by environments containing beta-D-GlcpNAc-(1->2)-beta-D-Galp-(1->3)-alpha-D-GalpNAc

Phenotype affecting beta-D-GlcpNAc-(1->2)-beta-D-Galp-(1->3)-alpha-D-GalpNAc

Human Disease Model